2019 Speakers

Mohamed Abdel-Hady, Pharmacovigilance And Epidemiology Manager, Gilead Sciences

Mohamed Abdel-Hady | Pharmacovigilance And Epidemiology Manager | Gilead Sciences » speaking at Drug Safety Congress

Anupam Agarwal, Vice President Global Head Of Drug Safety And Pv, Zogenix

Anupam Agarwal | Vice President Global Head Of Drug Safety And Pv | Zogenix » speaking at Drug Safety Congress

Omar Aimer, Pharmacovigilance specialist, Brunel-Sanofi

Omar Aimer | Pharmacovigilance specialist | Brunel-Sanofi » speaking at Drug Safety Congress

Saeed Amin, Managing Director, NHT

Saeed Amin | Managing Director | NHT » speaking at Drug Safety Congress

Julia Appelskog, Head Of Pv Strategy, Merck Group

Julia Appelskog | Head Of Pv Strategy | Merck Group » speaking at Drug Safety Congress

Felix Arellano, Global Head Safety Risk Management, F.Hoffmann-La Roche

Felix Arellano | Global Head Safety Risk Management | F.Hoffmann-La Roche » speaking at Drug Safety Congress

Deepa Arora, Independent

Deepa Arora |  | Independent » speaking at Drug Safety Congress

Elizabeth Baker, Pharmaceutical Policy Program Director, Physicians Committee for Responsible Medicine

Elizabeth Baker | Pharmaceutical Policy Program Director | Physicians Committee for Responsible Medicine » speaking at Drug Safety Congress

Nicole Baker, Independent

Nicole Baker |  | Independent » speaking at Drug Safety Congress

Mate Balazs, Country Head – Patient Safety – Hungary National QPPV – Hungary, Novartis Pharma AG

Mate Balazs | Country Head – Patient Safety – Hungary National QPPV – Hungary | Novartis Pharma AG » speaking at Drug Safety Congress

Steven Beales, SVP, Scientific and Regulatory, WCG Clinical

Steven Beales | SVP, Scientific and Regulatory | WCG Clinical » speaking at Drug Safety Congress

Rachna Bedi, Senior Lead Renal Pharmacist, Imperial College London

Rachna Bedi | Senior Lead Renal Pharmacist | Imperial College London » speaking at Drug Safety Congress

Scott Beebe, Director of Product Strategy, Wolters Kluwer

Scott Beebe | Director of Product Strategy | Wolters Kluwer » speaking at Drug Safety Congress

Albert Befki, Head of Global PV Operations, Gedeon Richter Plc

Albert Befki | Head of Global PV Operations | Gedeon Richter Plc » speaking at Drug Safety Congress

Arvind Bellur, Senior Director, Head Of Safety Data Management, Sanofi

Arvind Bellur | Senior Director, Head Of Safety Data Management | Sanofi » speaking at Drug Safety Congress

Pankaj Bhardwaj, Deputy Manager- Medico Marketing & Pharmacovigilance (International Business), Cadila Pharmaceuticals

Pankaj Bhardwaj | Deputy Manager- Medico Marketing & Pharmacovigilance (International Business) | Cadila Pharmaceuticals » speaking at Drug Safety Congress

Raj Bhogal, Regulatory Inspection Lead, Safety And International, R&D Quality Assurance And Compliance, Takeda Pharmaceuticals

Raj Bhogal | Regulatory Inspection Lead, Safety And International, R&D Quality Assurance And Compliance | Takeda Pharmaceuticals » speaking at Drug Safety Congress

Matthias Boedding, Head Global Drug Safety Medicine, Merck Group

Matthias Boedding | Head Global Drug Safety Medicine | Merck Group » speaking at Drug Safety Congress

Mariette Boerstoel-Streefland, Senior Vice President Of Pharmacovigilance And Drug Safety, Alexion Pharmaceuticals

Mariette Boerstoel-Streefland | Senior Vice President Of Pharmacovigilance And Drug Safety | Alexion Pharmaceuticals » speaking at Drug Safety Congress

Christelle Boeynaems, Multi Country Safety Lead Benelux, Sanofi

Christelle Boeynaems | Multi Country Safety Lead Benelux | Sanofi » speaking at Drug Safety Congress

Tracey Boone, Director, Business Technology - Case Processing Center Of Expertise Rsi Officer, AbbVie

Tracey Boone | Director, Business Technology - Case Processing Center Of Expertise Rsi Officer | AbbVie » speaking at Drug Safety Congress

Amanda Bowles, Specialist Leader, Deloitte Consulting LLP

Amanda Bowles | Specialist Leader | Deloitte Consulting LLP » speaking at Drug Safety Congress

Glenn Carroll, Principal, Deloitte Consulting LLP

Glenn Carroll | Principal | Deloitte Consulting LLP » speaking at Drug Safety Congress

Patrick Caubel, Senior Vice President, Pharmacovigilance, Pfizer

Patrick Caubel | Senior Vice President, Pharmacovigilance | Pfizer » speaking at Drug Safety Congress

Scott Chandler, Vice President And Global Head Licensing And Early Development (Lead) Safety, F. Hoffmann - La Roche

Scott Chandler | Vice President And Global Head Licensing And Early Development (Lead) Safety | F. Hoffmann - La Roche » speaking at Drug Safety Congress

Rosalee Chingara, Director-Business Development & Project Management, Sophos IT Services

Rosalee Chingara | Director-Business Development & Project Management | Sophos IT Services » speaking at Drug Safety Congress

David Chonzi, Vice President, Head Of Pharmacovigilance And Epidemiology ( Pve), Allogene Therapeutics

David Chonzi | Vice President, Head Of Pharmacovigilance And Epidemiology ( Pve) | Allogene Therapeutics » speaking at Drug Safety Congress

Rishi Chopra, Senior Director, Head of International Pharmacovigilance (IPV), Deputy EU QPPV, GSRS, Biogen

Rishi Chopra | Senior Director, Head of International Pharmacovigilance (IPV), Deputy EU QPPV,  GSRS | Biogen » speaking at Drug Safety Congress

Salvatore Giorgio Cicirello, Senior Director Pharmacovigilance Innovation, Global Drug Safety And Risk Management, Celgene

Salvatore Giorgio Cicirello | Senior Director Pharmacovigilance Innovation, Global Drug Safety And Risk Management | Celgene » speaking at Drug Safety Congress

Mircea Ciuca, Global Therapeutic Area Head Of Global Clinical Safety And Pharmacovigilance, CSL Behring

Mircea Ciuca | Global Therapeutic Area Head Of Global Clinical Safety And Pharmacovigilance | CSL Behring » speaking at Drug Safety Congress

Elizabeth Ciyou Allee, Senior Director, AbbVie

Elizabeth Ciyou Allee | Senior Director | AbbVie » speaking at Drug Safety Congress

Margherita D'Antuono, E.U. Q.P.P.V., Italfarmaco S.P.A.

Margherita D'Antuono | E.U. Q.P.P.V. | Italfarmaco S.P.A. » speaking at Drug Safety Congress

April Davis, Global Pharmacovigilance Industry Director, Accenture

April Davis | Global Pharmacovigilance Industry Director | Accenture » speaking at Drug Safety Congress

Carola Gómez De La Bárcena, QPPV, Laboratorios Farmaceuticos Rovi

Carola Gómez De La Bárcena | QPPV | Laboratorios Farmaceuticos Rovi » speaking at Drug Safety Congress

Carola Gómez De La Bárcena, QPPV, Laboratorios Farmaceuticos Rovi

Carola Gómez De La Bárcena | QPPV | Laboratorios Farmaceuticos Rovi » speaking at Drug Safety Congress

Carlos De Pablos Martinez, Local Qualified Person Responsible For Pharmacovigilance (Lqppv), Grifols

Carlos De Pablos Martinez | Local Qualified Person Responsible For Pharmacovigilance (Lqppv) | Grifols » speaking at Drug Safety Congress

Peter De Veene, Qppv, Alexion Pharmaceuticals

Peter De Veene | Qppv | Alexion Pharmaceuticals » speaking at Drug Safety Congress

Wivina De Waele, Regional Drug Safety Office, Alexion Pharmaceuticals

Wivina De Waele | Regional Drug Safety Office | Alexion Pharmaceuticals » speaking at Drug Safety Congress

Moin Don, Chief Executive Officer And Founder, P.V.C.O.N. Pharmacovigilance Auditing and Consulting Services

Moin Don | Chief Executive Officer And Founder | P.V.C.O.N. Pharmacovigilance Auditing and Consulting Services » speaking at Drug Safety Congress

Marjan Dzeparoski, Ra & Pv, Bionika Pharmaceuticals

Marjan Dzeparoski | Ra & Pv | Bionika Pharmaceuticals » speaking at Drug Safety Congress

Philip Eichorn, senior director, Pfizer Ltd

Philip Eichorn | senior director | Pfizer Ltd » speaking at Drug Safety Congress

Maritess Esguerra, Principal Pharmacovigilance Process Leader, Genentech

Maritess Esguerra | Principal Pharmacovigilance Process Leader | Genentech » speaking at Drug Safety Congress

Nadia Espanol, Senior Global Drug Safety Specialist, mAbxience

Nadia Espanol | Senior Global Drug Safety Specialist | mAbxience » speaking at Drug Safety Congress

Philippa Evans, Safety Medical Writer, Novo Nordisk

Philippa Evans | Safety Medical Writer | Novo Nordisk » speaking at Drug Safety Congress

Timo Faltus, Research Associate, Pi, Martin-Luther-University Halle-Wittenberg, Germany

Timo Faltus | Research Associate, Pi | Martin-Luther-University Halle-Wittenberg, Germany » speaking at Drug Safety Congress

Santiago Garnica Velandia, Drug Safety Coordinator, VITALIS SACI

Santiago Garnica Velandia | Drug Safety Coordinator | VITALIS SACI » speaking at Drug Safety Congress

Stewart Geary, Senior Vice President, Chief Medical Officer, Director, Corporate Medical Affairs Headquarters, Eisai

Stewart Geary | Senior Vice President, Chief Medical Officer, Director, Corporate Medical Affairs Headquarters | Eisai » speaking at Drug Safety Congress

Essam Ghanem, Head Of Drug Safety And Pharmacovigilance (Dspv), Vigi-Care

Essam Ghanem | Head Of Drug Safety And Pharmacovigilance (Dspv) | Vigi-Care » speaking at Drug Safety Congress

Trevor Gibbs, Chief Scientific Officer & Co-Founder, MyMedsandMe

Trevor Gibbs | Chief Scientific Officer & Co-Founder | MyMedsandMe » speaking at Drug Safety Congress

Lykke Bjerglund Graff, Head Of Global Safety, LEO Pharma

Lykke Bjerglund Graff | Head Of Global Safety | LEO Pharma » speaking at Drug Safety Congress

Liana Gross Martirosyan, Alternate Prac Member, Netherlands

Liana Gross Martirosyan | Alternate Prac Member | Netherlands » speaking at Drug Safety Congress

Uwe Gudat, Head Of Clinical Safety And Pharmacovigilance Clinical Safety And Pharmacovigilance, Fresenius Kabi

Uwe Gudat | Head Of Clinical Safety And Pharmacovigilance Clinical Safety And Pharmacovigilance | Fresenius Kabi » speaking at Drug Safety Congress

Jefferson Guillon, Pharmacovigilance Manager And Eea Qppv, Seqirus

Jefferson Guillon | Pharmacovigilance Manager And Eea Qppv | Seqirus » speaking at Drug Safety Congress

Israel Gutierrez, Vice President Pharmacovigilance And Drug Safety, Geron Corporation

Israel Gutierrez | Vice President Pharmacovigilance And Drug Safety | Geron Corporation » speaking at Drug Safety Congress

Marqus Hamwright, Senior Director, Argenx

Marqus Hamwright | Senior Director | Argenx » speaking at Drug Safety Congress

Fabian Heisig, Head Of Safety, Benefit Risk And Global Drug Safety, Grunenthal

Fabian Heisig | Head Of Safety, Benefit Risk And Global Drug Safety | Grunenthal » speaking at Drug Safety Congress

wendy Huisman, Managing Director, Vigifit

wendy Huisman | Managing Director | Vigifit » speaking at Drug Safety Congress

Ashish Jain, Associate Director, Syros Pharmaceuticals

Ashish Jain | Associate Director | Syros Pharmaceuticals » speaking at Drug Safety Congress

Rotimi Jaiyesimi, Associate Medical Director For Patient Safety, Basildon University Hospital NHS Foundation Trust

Rotimi Jaiyesimi | Associate Medical Director For Patient Safety | Basildon University Hospital NHS Foundation Trust » speaking at Drug Safety Congress

Sheila Khawaja, Vice Chair, WAPO Association

Sheila Khawaja | Vice Chair | WAPO Association » speaking at Drug Safety Congress

Mariska Kooijmans-Coutinho, Head Of Pharmacovigilance International And Eu Qpp, Amicus Therapeutics U.K. Ltd

Mariska Kooijmans-Coutinho | Head Of Pharmacovigilance International And Eu Qpp | Amicus Therapeutics U.K. Ltd » speaking at Drug Safety Congress

Sergiy Kryvych, Drug Safety Officer, Pfizer

Sergiy Kryvych | Drug Safety Officer | Pfizer » speaking at Drug Safety Congress

Manni Kuthiala, Pv Affiliate Strategic Alliance Manager, Roche

Manni Kuthiala | Pv Affiliate Strategic Alliance Manager | Roche » speaking at Drug Safety Congress

Pedro Lima, Regions Medical Safety Head, Sanofi

Pedro Lima | Regions Medical Safety Head | Sanofi » speaking at Drug Safety Congress

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen | Medical Director | Norwegian Medicines Agency, Norway » speaking at Drug Safety Congress

Valentina Mancini, Director Pharmacovigilance/ Eu Qppv, Shionogi Inc

Valentina Mancini | Director Pharmacovigilance/ Eu Qppv | Shionogi Inc » speaking at Drug Safety Congress

Monika Manske, Associate Director Of Global Pharmacovigilance Governance, Mylan

Monika Manske | Associate Director Of Global Pharmacovigilance Governance | Mylan » speaking at Drug Safety Congress

Muriel Marks - De Korver, Executive Director, WAPO Association

Muriel Marks - De Korver | Executive Director | WAPO Association » speaking at Drug Safety Congress

Rie Matsui, Director, Regional Labeling Head Of Asia, Pfizer

Rie Matsui | Director, Regional Labeling Head Of Asia | Pfizer » speaking at Drug Safety Congress

Jorgen Matz, Head Of Global Pharmacovigilance And Drug Safety, Insud Pharma

Jorgen Matz | Head Of Global Pharmacovigilance And Drug Safety | Insud Pharma » speaking at Drug Safety Congress

Andrea Maulwurf, Head Of Pharmacovigilance, Eu-Qppv, Allergy Therapeutics

Andrea Maulwurf | Head Of Pharmacovigilance, Eu-Qppv | Allergy Therapeutics » speaking at Drug Safety Congress

Adrian Maynier, Project Lead, UCB

Adrian Maynier | Project Lead | UCB » speaking at Drug Safety Congress

Steven Mcmahon, Director, Irish Patient Association

Steven Mcmahon | Director | Irish Patient Association » speaking at Drug Safety Congress

Adi Meister, Safety Strategy, Teva Pharmaceuticals

Adi Meister | Safety Strategy | Teva Pharmaceuticals » speaking at Drug Safety Congress

Tarik Messaoud, Drug Safety Specialist Pharmacovigilance Specialist, Merck

Tarik Messaoud | Drug Safety Specialist Pharmacovigilance Specialist | Merck » speaking at Drug Safety Congress

Tarrik Messaoud, Independant

Tarrik Messaoud |  | Independant » speaking at Drug Safety Congress

Sutirtha Mukhopadhyay, Global Safety Officer, Sanofi

Sutirtha Mukhopadhyay | Global Safety Officer | Sanofi » speaking at Drug Safety Congress

Muhammad Ashar Naeem, Global Director Pharmacovigilance And Medical Affair, Jamjoom Pharma

Muhammad  Ashar Naeem | Global Director Pharmacovigilance And Medical Affair | Jamjoom Pharma » speaking at Drug Safety Congress

Jaylaxmi Nalawade, Associate Director, Lupin Ltd

Jaylaxmi Nalawade | Associate Director | Lupin Ltd » speaking at Drug Safety Congress

Dave Nestor, Director, Deloitte

Dave Nestor | Director | Deloitte » speaking at Drug Safety Congress

Andrew Olaharski, Senior Director And Head Of Toxicology, K.S.Q. Therapeutics

Andrew Olaharski | Senior Director And Head Of Toxicology | K.S.Q. Therapeutics » speaking at Drug Safety Congress

Esther Onolememen, Chief Executive Officer And Founder, Sickle Cell Society Ireland

Esther Onolememen | Chief Executive Officer And Founder | Sickle Cell Society Ireland » speaking at Drug Safety Congress

Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC

Nneka Onwudiwe | Founder And Chief Executive Officer | Pharmaceutical Economics Consultants of America (PECA) LLC » speaking at Drug Safety Congress

Bruce Palsulich, Vice President Product Strategy, Oracle Health Sciences

Bruce Palsulich | Vice President Product Strategy | Oracle Health Sciences » speaking at Drug Safety Congress

Dr Raphael Pareschi, Pharmacovigilance Associate Director, Pv Country Lead Deputy, Merck

Dr Raphael Pareschi | Pharmacovigilance Associate Director, Pv Country Lead Deputy | Merck » speaking at Drug Safety Congress

Vladimir Penkrat, Associate Vice President, Indegene

Vladimir Penkrat | Associate Vice President | Indegene » speaking at Drug Safety Congress

Tanja Peters, Deputy Eu-Qppv, Head Pv Intelligence, Boehringer Ingelheim Pharma GmbH & Co. KG

Tanja Peters | Deputy Eu-Qppv, Head Pv Intelligence | Boehringer Ingelheim Pharma GmbH & Co. KG » speaking at Drug Safety Congress

Anastasia Philippova, Qppv, Geropharm

Anastasia Philippova | Qppv | Geropharm » speaking at Drug Safety Congress

Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP

Mary Lynne Van Poelgeest-Pomfret | President | President of the World Federation for Incontinence and Pelvic Pain - WFIP » speaking at Drug Safety Congress

Vivek Poojary, Senior Manager Pharmacovigilance, Alkem Laboratories Limited

Vivek Poojary | Senior Manager Pharmacovigilance | Alkem Laboratories Limited » speaking at Drug Safety Congress

John Poustie, Senior Director, Qppv Global Pharmacovigilance, Norgine Ltd

John Poustie | Senior Director, Qppv Global Pharmacovigilance | Norgine Ltd » speaking at Drug Safety Congress

Nicolas Praet, Senior Epidemiologist Director, GlaxoSmithKline

Nicolas Praet | Senior Epidemiologist Director | GlaxoSmithKline » speaking at Drug Safety Congress

Elena Prokofyeva, Head Of Drug Safety Unit, Department Of R&D, A.F.M.P.S

Elena Prokofyeva | Head Of Drug Safety Unit, Department Of R&D | A.F.M.P.S » speaking at Drug Safety Congress

Rohit Pushparajan, R&D Operations Lead Europe, Accenture

Rohit Pushparajan | R&D Operations Lead Europe | Accenture » speaking at Drug Safety Congress

Rohit Pushparajan, R&D Operations Lead Europe, Accenture

Rohit Pushparajan | R&D Operations Lead Europe | Accenture » speaking at Drug Safety Congress

Nawab Qizilbash, Senior Clinical Epidemiologist (Honorary Associate Professor, London School of Hygiene and Tropical Medicine), Oxon Epidemiology

Nawab Qizilbash | Senior Clinical Epidemiologist (Honorary Associate Professor, London School of Hygiene and Tropical Medicine) | Oxon Epidemiology » speaking at Drug Safety Congress

Nibedita Rath, Scientific Director, Open Source Pharma Foundation

Nibedita Rath | Scientific Director | Open Source Pharma Foundation » speaking at Drug Safety Congress

Susanne Reymann, Head Pv Quality Systems And Compliance, Abbott Laboratories GmbH

Susanne Reymann | Head Pv Quality Systems And Compliance | Abbott Laboratories GmbH » speaking at Drug Safety Congress

Jackie Roberts, Executive Director - Regulatory, Pharmacovigilance And Medical, Accord Healthcare

Jackie Roberts | Executive Director - Regulatory, Pharmacovigilance And Medical | Accord Healthcare » speaking at Drug Safety Congress

Angela Caro Rojas, President, Colombian Pharmacovigilance Association

Angela Caro Rojas | President | Colombian Pharmacovigilance Association » speaking at Drug Safety Congress

Marco Sardella, Chief Pharmacovigilance Officer And Q.P.P.V. For Europe, Adienne

Marco Sardella | Chief Pharmacovigilance Officer And Q.P.P.V. For Europe | Adienne » speaking at Drug Safety Congress

Marcus Schartau, Safety Surveillance Risk Management Specialist, Safety Surveillance, Novo Nordisk A/S

Marcus Schartau | Safety Surveillance Risk Management Specialist, Safety Surveillance | Novo Nordisk A/S » speaking at Drug Safety Congress

Rudi Scheerlinck, Global Head Pharmacovigilance Risk Management, Nestle Skin Health

Rudi Scheerlinck | Global Head Pharmacovigilance Risk Management | Nestle Skin Health » speaking at Drug Safety Congress

Hildia Schreuder, Country Safety Lead, Sanofi

Hildia Schreuder | Country Safety Lead | Sanofi » speaking at Drug Safety Congress

Vipin Sethi, Head – Global Pharmacovigilance and Medical Affairs, Cadila Pharmaceuticals

Vipin Sethi | Head – Global Pharmacovigilance and Medical Affairs | Cadila Pharmaceuticals » speaking at Drug Safety Congress

Akhilesh Sharma, President and Chief Medical Officer, Alkem Laboratories Ltd

Akhilesh Sharma | President and Chief Medical Officer | Alkem Laboratories Ltd » speaking at Drug Safety Congress

Grishma Sharma, Managing Director, Accenture

Grishma Sharma | Managing Director | Accenture » speaking at Drug Safety Congress

Priya Singhal, Head of Research & Development, Zafgen, Inc.

Priya Singhal | Head of Research & Development | Zafgen, Inc. » speaking at Drug Safety Congress

Howard Snow, Howard Snow, Head Patient Safety, Sandoz Biopharmaceuticals, Chief Medical Office And Patient Safety, Novartis International AG

Howard Snow | Howard Snow, Head Patient Safety, Sandoz Biopharmaceuticals, Chief Medical Office And Patient Safety | Novartis International AG » speaking at Drug Safety Congress

Katrien Soleme, Head Of Global Quality Regulatory Compliance And Clinical Trials And Safety, Bristol Myers Squibb

Katrien Soleme | Head Of Global Quality Regulatory Compliance And Clinical Trials And Safety | Bristol Myers Squibb » speaking at Drug Safety Congress

John Solomon, Head Of Pharmacovigilance, Sanofi

John Solomon | Head Of Pharmacovigilance | Sanofi » speaking at Drug Safety Congress

Anna Sommerville, Accenture

Anna Sommerville |  | Accenture » speaking at Drug Safety Congress

Natalie Springveld, Global Safety Leader, Bayer Basel

Natalie Springveld | Global Safety Leader | Bayer Basel » speaking at Drug Safety Congress

Doris Stenver, Former Chief Medical Officer, Member Of Prac At Ema, Danish Medicines Agency

Doris Stenver | Former Chief Medical Officer, Member Of Prac At Ema | Danish Medicines Agency » speaking at Drug Safety Congress

Marina Suvakov, Director, Compliance And Business Management, Otsuka Europe Development and Commercialisation Ltd

Marina Suvakov | Director, Compliance And Business Management | Otsuka Europe Development and Commercialisation Ltd » speaking at Drug Safety Congress

Qi Tang, Associate Director Of Digital and Data Sciences, Sanofi

Qi Tang | Associate Director Of Digital and Data Sciences | Sanofi » speaking at Drug Safety Congress

Nasim Tavakoli, Group Drug Safety Manager - Operations, F. Hoffmann-La Roche Ltd

Nasim Tavakoli | Group Drug Safety Manager - Operations | F. Hoffmann-La Roche Ltd » speaking at Drug Safety Congress

Maria Tello, Head Of Safety, Rakuten Medical

Maria Tello | Head Of Safety | Rakuten Medical » speaking at Drug Safety Congress

Francesco Tescione, Eu Qualified Person For Pharmacovigilance Qppv, Molteni Farmaceutici

Francesco Tescione | Eu Qualified Person For Pharmacovigilance Qppv | Molteni Farmaceutici » speaking at Drug Safety Congress

Sivakumar Thiagarajan, VP and Head of R&D, Indegene

Sivakumar Thiagarajan | VP and Head of R&D | Indegene » speaking at Drug Safety Congress

Shani Thilak, Senior Manager - Advisory, Kinapse Ltd

Shani Thilak | Senior Manager - Advisory | Kinapse Ltd » speaking at Drug Safety Congress

Ricarda Tiemeyer, Head Of Drug Safety, Biogen

Ricarda Tiemeyer | Head Of Drug Safety | Biogen » speaking at Drug Safety Congress

Klaudia Traudtner, Head of Pharmacovigilance and Safety, Kiadis Pharma

Klaudia Traudtner | Head of Pharmacovigilance and Safety | Kiadis Pharma » speaking at Drug Safety Congress

Phil Tregunno, Signal Management Unit Manager, And Imi Web-Radr Project Lead, Medicines & Healthcare Products Regulatory Agency

Phil Tregunno | Signal Management Unit Manager, And Imi Web-Radr Project Lead | Medicines & Healthcare Products Regulatory Agency » speaking at Drug Safety Congress

Shinobu Uzu, Associate Executive Director, Pharmaceuticals and Medical Devices Agency

Shinobu Uzu | Associate Executive Director | Pharmaceuticals and Medical Devices Agency » speaking at Drug Safety Congress

Lionel Van Holle, Safety Surveillance Lead, UCB

Lionel Van Holle | Safety Surveillance Lead | UCB » speaking at Drug Safety Congress

Bert Van Leeuwen, Deputy Qppv, Astellas Pharma Europe BV

Bert Van Leeuwen | Deputy Qppv | Astellas Pharma Europe BV » speaking at Drug Safety Congress

Dennis Vargo, Vice President, Head of Drug Safety and Pharmacovigilance, Akebia Therapeutics , Inc.

Dennis Vargo | Vice President, Head of Drug Safety and Pharmacovigilance | Akebia Therapeutics , Inc. » speaking at Drug Safety Congress

Ale Maria Vazquez-Gragg, Vice President Of Global Patient Safety, Argenx

Ale Maria Vazquez-Gragg | Vice President Of Global Patient Safety | Argenx » speaking at Drug Safety Congress

Archi Wani, Principal Map Vendor Compliance Lead Us Drug Safety, Market Research And Patient Support Programs, Genentech

Archi Wani | Principal Map Vendor Compliance Lead Us Drug Safety, Market Research And Patient Support Programs | Genentech » speaking at Drug Safety Congress

Hal Ward, Director Of Executive Drug Safety Surveillance, Kyowa Hakko Kirin Co Ltd

Hal Ward | Director Of Executive Drug Safety Surveillance | Kyowa Hakko Kirin Co Ltd » speaking at Drug Safety Congress

Aman Wasan, Vice President, Global Pv and Global Client Partners, ArisGlobal

Aman Wasan | Vice President, Global Pv and Global Client Partners | ArisGlobal » speaking at Drug Safety Congress

Heinz Weidenthaler, Director Pharmacovigilance, Qppv, Bavarian Nordic

Heinz Weidenthaler | Director Pharmacovigilance, Qppv | Bavarian Nordic » speaking at Drug Safety Congress

James Whitehead, Principal, Astra Zeneca

James Whitehead | Principal | Astra Zeneca » speaking at Drug Safety Congress

Songlin Xue, Executive Vice President And Global Head Of Pharmacovigilance, Astellas Pharma

Songlin Xue | Executive Vice President And Global Head Of Pharmacovigilance | Astellas Pharma » speaking at Drug Safety Congress

Syed Zaferuddin, Deputy Qppv+ Pharmacovigilance And Clinical Trial Manager, Julphar

Syed Zaferuddin | Deputy Qppv+ Pharmacovigilance And Clinical Trial Manager | Julphar » speaking at Drug Safety Congress

Get Involved At World Drug Safety Congress

 

To Sponsor Or Exhibit


Edmond Rama
edmond.rama@terrapinn.com
+44 20 7092 1052

 

 

 

To Speak


Anastasia Beretsos
Anastasia.Beretsos@terrapinn.com
+44 20 7092 1070

 

 

 

To Register


Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210